🔎 Trials Near Me

Gara Jalqabaatti › Limfomaa T-Selii › California

Qorannoo klinikaalii Limfomaa T-Selii California keessatti

Qorannoo 13 Limfomaa T-Selii f California keessatti hirmaatuu jiru.

Magaalota California keessatti

Takkalaa qorannoo (Ingiliffa)

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

  • City of Hope Medical Foundation, Duarte
  • University of Southern California, Los Angeles
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04234048

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

  • Cedars-Sinai Medical Center, Los Angeles
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04803201

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

  • City of Hope National Medical Center, Duarte
  • University of California, Irvine, Irvine
  • University of California San Francisco, San Francisco
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06561048

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

  • City of Hope National Medical Center, Duarte
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT04752826

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
  • City of Hope Comprehensive Cancer Center, Duarte
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06724237

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

  • City of Hope Comprehensive Cancer Cente, Duarte
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06854653

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

  • Rady Children's Hospital, San Diego
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06390319

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

  • City of Hope Medical Center, Duarte
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07293403

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

  • City of Hope Medical Center, Duarte
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT03011814

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

  • City of Hope Medical Center, Duarte
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Wax-2026 · NCT07278856

A Registry for People With T-cell Lymphoma

  • City of Hope Cancer Center (Data collection only), Duarte
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only), San Diego
  • University of California San Francisco (Data collection only), San Francisco
  • fi 1 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT05978141

MB-105 in Patients With CD5 Positive T-cell Lymphoma

  • University of San Diego (UCSD)-Moores Cancer Center, San Diego
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Onk-2025 · NCT06534060

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital Orange County, Orange
  • UCSF School of Medicine, San Francisco
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.